Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	91.34B -8.4%
Revenue (ttm)	41.95B +4.6%
Net Income	5.26B +5.5%
EPS	2.95 +5.7%
Shares Out	1.78B
PE Ratio	17.36
Forward PE	15.70
Dividend	2.60 (5.13%)
Ex-Dividend Date	Apr 30, 2026

Volume	5,993,760
Open	51.01
Previous Close	51.19
Day's Range	50.81 - 51.43
52-Week Range	46.29 - 60.69
Beta	0.10
Analysts	Strong Buy
Price Target	69.15 (+35.4%)
Earnings Date	Aug 29, 2026

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmace...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,286
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2025, SHE:000538's revenue was 41.19 billion, an increase of 2.88% compared to the previous year's 40.03 billion. Earnings were 5.15 billion, an increase of 8.51%.

Analyst Summary

According to 11 analysts, the average rating for 000538 stock is "Strong Buy." The 12-month stock price target is ¥69.15, which is an increase of 35.40% from the latest price.

Price Target

¥69.15

(35.40% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 11, 2026

Data Sources Report a data error